Legend Biotech (LEGN) Non-Current Deferred Tax Liability (2019 - 2021)
Legend Biotech's (LEGN) quarterly Non-Current Deferred Tax Liability came in at $22.8 million in Q4 2021, down 35.05% YoY from $35.0 million in Q4 2020, and down 35.05% on a QoQ basis from $35.0 million in Q4 2020.
Legend Biotech (LEGN) Non-Current Deferred Tax Liability (2019 - 2021) Analysis & Trends
Legend Biotech (LEGN) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $22.8 million in Q4 2021.
- Quarterly Non-Current Deferred Tax Liability fell 35.05% year-over-year to $22.8 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $22.8 million (down 35.05% YoY) and the FY2021 annual result came in at $22.8 million, down 35.05% from the prior year.
- Non-Current Deferred Tax Liability slipped to $22.8 million in Q4 2021, from $35.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $47.7 million in Q4 2019 to a low of $22.8 million in Q4 2021.
- A 3-year average of $35.2 million and a median of $35.0 million in 2020 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2020 — Non-Current Deferred Tax Liability slipped 26.54% — and 2021, when it plunged 35.05%.
- Tracing LEGN's Non-Current Deferred Tax Liability over 3 years: stood at $47.7 million in 2019, then fell by 26.54% to $35.0 million in 2020, then sank by 35.05% to $22.8 million in 2021.
- The last three Non-Current Deferred Tax Liability figures came in at $22.8 million (Q4 2021), $35.0 million (Q4 2020), and $47.7 million (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 22.76 Mn |
| Dec 31, 2021 | 22.76 Mn |
| Dec 31, 2020 | 35.04 Mn |
| Dec 31, 2020 | 35.04 Mn |
| Dec 31, 2019 | 47.70 Mn |
| Dec 31, 2019 | 47.70 Mn |